<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39252862</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2451-8654</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Contemporary clinical trials communications</Title><ISOAbbreviation>Contemp Clin Trials Commun</ISOAbbreviation></Journal><ArticleTitle>Recruitment and retention of pediatric participants for pandemic preparedness research: Experience from the PREMISE EV-D68 Pilot Study.</ArticleTitle><Pagination><StartPage>101351</StartPage><MedlinePgn>101351</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101351</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.conctc.2024.101351</ELocationID><Abstract><AbstractText>Recruitment and retention are challenges for prospective pediatric cohort studies, particularly those involving serial venipunctures. We investigated factors underlying enrollment and retention in the Pandemic Response Repository through Microbial and Immune Surveillance and Epidemiology (PREMISE) Enterovirus D68 (EV-D68) Pilot Study, a multicenter prospective longitudinal cohort study assessing the utility of immunologic surveillance for pandemic preparedness. This study enrolls children ≤10 years for two blood draws, pre- and post-EV-D68 season, separated by 6-18 months. Overall, 174 children were enrolled in Cohort 1 of the study and 120 (69 %) of children completed the study, with follow-up blood samples obtained from 101 (58 %) of participants. Families were primarily motivated to participate by a desire to help other children, advance science, and better prepare for the next pandemic. Adding research blood draws to clinically indicated blood draws improved enrollment, and multiple study touch points facilitated retention. These findings can be applied to improve recruitment and retention in future pandemic preparedness efforts and longitudinal pediatric cohort studies.</AbstractText><CopyrightInformation>© 2024 The Authors. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen-Tran</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine &amp; Children's Hospital Colorado, Department of Pediatrics, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spaulding</LastName><ForeName>Alicen B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messacar</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine &amp; Children's Hospital Colorado, Department of Pediatrics, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogt</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, School of Medicine, Department of Pediatrics, Chapel Hill, NC, 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, School of Medicine, Department of Microbiology and Immunology, Chapel Hill, NC, 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Permaul</LastName><ForeName>Perdita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Weill Cornell Medical College &amp; New York-Presbyterian Hospital, Department of Pediatrics, New York, NY, 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douek</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittelman</LastName><ForeName>Abe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Careese</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine &amp; Children's Hospital Colorado, Department of Pediatrics, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grubbs</LastName><ForeName>Sandy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, School of Medicine, Department of Pediatrics, Chapel Hill, NC, 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magana</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Weill Cornell Medical College &amp; New York-Presbyterian Hospital, Department of Pediatrics, New York, NY, 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Michelle L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>University of North Carolina at Chapel Hill, School of Medicine, Department of Pediatrics, Chapel Hill, NC, 27599, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 AI156125</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI169461</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Contemp Clin Trials Commun</MedlineTA><NlmUniqueID>101671157</NlmUniqueID><ISSNLinking>2451-8654</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cohort study</Keyword><Keyword MajorTopicYN="N">Pandemic preparedness</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Recruitment</Keyword><Keyword MajorTopicYN="N">Retention</Keyword></KeywordList><CoiStatement>The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: HN-T received funding from the Centers for Disease Control and Prevention for her involvement in the “Duration of Enterovirus D68 Shedding from the Upper Respiratory Tract” study and received support from the Congenital and Perinatal Infections Consortium (CPIC) and Cambridge Innovation Institute for conference attendance at IDWeek (2022, 2023) and Next Generation Dx Summit (2023), respectively. AS and AM receive support from the NIH, NIAID Vaccine Research Center. MRV receives support from the following grants/contracts: K08AI156125, 75N91019D00024, R01AI169461; received honorariums for lectures from NIAID, Uniformed Services University, University of Maryland-Baltimore, Duke University, Baylor College of Medicine; and has a patent application pending (PCT/US2020/043,415). MLH receives support from the NIH, NIAID Vaccine Research Center; reports the following grants: NHLBI-R01, NCATS-CTSA K12; NCATS-UM1; NSF-SCH; participates in the GSK Advisory Board for asthma; and is the AAAAI EORD Interest Section Vice Chair.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39252862</ArticleId><ArticleId IdType="pmc">PMC11381461</ArticleId><ArticleId IdType="doi">10.1016/j.conctc.2024.101351</ArticleId><ArticleId IdType="pii">S2451-8654(24)00098-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute of Allergy and Infectious Diseases  NIAID pandemic preparedness plan. https://www.niaid.nih.gov/sites/default/files/pandemic-preparedness-plan.pdf</Citation></Reference><Reference><Citation>National Institute of Allergy and Infectious Diseases. PREMISE Program. Accessed February 15, 2024. https://www.niaid.nih.gov/research/premise.</Citation></Reference><Reference><Citation>Nguyen-Tran H., Park S.W., Messacar K., et al. Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens. Lancet Microbe. Feb 2022;3(2):e83–e85. doi: 10.1016/s2666-5247(21)00312-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-5247(21)00312-8</ArticleId><ArticleId IdType="pmc">PMC8741221</ArticleId><ArticleId IdType="pubmed">35036969</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindhu K.N., Srinivasan M., Subramaniam S., et al. Why do participants drop-out: findings from a prospective pediatric cohort for fever surveillance established at Vellore, Southern India. BMC Med. Res. Methodol. Dec 30 2019;19(1):244. doi: 10.1186/s12874-019-0881-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-019-0881-y</ArticleId><ArticleId IdType="pmc">PMC6937945</ArticleId><ArticleId IdType="pubmed">31888513</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickremsinhe E., West L., Short M., Talkington B. DIY blood sampling for pediatric clinical trials—the patients perspective. https://www.appliedclinicaltrialsonline.com/view/diy-blood-sampling-pediatric-clinical-trials-patients-perspective</Citation></Reference><Reference><Citation>Kadam R.A., Borde S.U., Madas S.A., Salvi S.S., Limaye S.S. Challenges in recruitment and retention of clinical trial subjects. Perspect Clin Res. Jul-Sep 2016;7(3):137–143. doi: 10.4103/2229-3485.184820.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2229-3485.184820</ArticleId><ArticleId IdType="pmc">PMC4936073</ArticleId><ArticleId IdType="pubmed">27453831</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson S.E., Smith P., Snowden J., et al. Facilitators and barriers to pediatric clinical trial recruitment and retention in rural and community settings: a scoping review of the literature. Clin Transl Sci. Apr 2022;15(4):838–853. doi: 10.1111/cts.13220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.13220</ArticleId><ArticleId IdType="pmc">PMC9010274</ArticleId><ArticleId IdType="pubmed">35037409</ArticleId></ArticleIdList></Reference><Reference><Citation>Denhoff E.R., Milliren C.E., de Ferranti S.D., Steltz S.K., Osganian S.K. Factors associated with clinical research recruitment in a pediatric academic medical center--A web-based survey. PLoS One. 2015;10(10) doi: 10.1371/journal.pone.0140768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0140768</ArticleId><ArticleId IdType="pmc">PMC4608599</ArticleId><ArticleId IdType="pubmed">26473602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathe J.M., Oskoui T.T., Weiss E.M. Parental views of facilitators and barriers to research participation: systematic review. Pediatrics. 2022;151(1) doi: 10.1542/peds.2022-058067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-058067</ArticleId><ArticleId IdType="pmc">PMC9808610</ArticleId><ArticleId IdType="pubmed">36477217</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. Apr 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Minor B.L., et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inf. Jul 2019;95 doi: 10.1016/j.jbi.2019.103208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>